Contact information
Research groups
Alison Lawrie
Senior Vaccine Development Co-ordinator & Head of Regulatory Affairs
Recent publications
-
Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Journal article
Folegatti PM. et al, (2021), Vaccines, 9, 262 - 262
-
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Journal article
Wilkie M. et al, (2020), Vaccine, 38, 779 - 789
-
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40
-
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
Journal article
Venkatraman N. et al, (2019), The Journal of Infectious Diseases, 219, 1187 - 1197
-
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
Journal article
Manjaly Thomas Z-R. et al, (2019), PLoS medicine, 16